Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia
โ Scribed by Robyn M. Hart; Richard G. Evans; Bruce F. Kimler; Chan H. Park
- Publisher
- Elsevier Science
- Year
- 1986
- Tongue
- English
- Weight
- 148 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background. Patients with ataxia-telangiectasia (A-T) are at an increased risk for developing lymphoid malignancies, yet the appropriate therapy remains unknown. Radiation therapy at conventional doses results in destruction of normal tissue, which has suggested that full-dose chemotherapy might res
The ataxia-telangiectasia mutated (ATM) gene, which is mutated in the autosomal recessive disorder ataxia-telangiectasia (AT), was isolated in 1995 by positional cloning. Although in vitro cell fusion studies had suggested that AT was genetically heterogeneous, all AT patients studied to date have b